Lippman SM - Search Results

1

Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis.

Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman SM. Clifford JL, et al. Among authors: lippman sm. Clin Cancer Res. 2002 Jul;8(7):2067-72. Clin Cancer Res. 2002. PMID: 12114405 Clinical Trial.

2

Determination of biomarkers for intermediate end points in chemoprevention trials.

Lee JS, Lippman SM, Hong WK, Ro JY, Kim SY, Lotan R, Hittelman WN. Lee JS, et al. Among authors: lippman sm. Cancer Res. 1992 May 1;52(9 Suppl):2707s-2710s. Cancer Res. 1992. PMID: 1348662 Review.

3

A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.

Schantz SP, Dimery I, Lippman SM, Clayman GL, Pellegrino C, Morice R. Schantz SP, et al. Among authors: lippman sm. Invest New Drugs. 1992 Aug;10(3):217-23. doi: 10.1007/BF00877250. Invest New Drugs. 1992. PMID: 1428731 Clinical Trial.

4

Recent advances in cancer chemoprevention.

Lippman SM, Hittelman WN, Lotan R, Pastorino U, Hong WK. Lippman SM, et al. Cancer Cells. 1991 Feb;3(2):59-65. Cancer Cells. 1991. PMID: 1674206

5

Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis.

Lippman SM, Toth BB, Batsakis JG, Weber RS, McCarthy KS, Hays GL, Wargovich MJ, Lee JS, Thacher S, Lotan R, et al. Lippman SM, et al. Prog Clin Biol Res. 1990;339:179-91. Prog Clin Biol Res. 1990. PMID: 1697415 No abstract available.

6

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK. Lippman SM, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):235-41. doi: 10.1093/jnci/84.4.235. J Natl Cancer Inst. 1992. PMID: 1734084 Clinical Trial.

7

13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff IH. Lippman SM, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):241-5. doi: 10.1093/jnci/84.4.241. J Natl Cancer Inst. 1992. PMID: 1734085 Clinical Trial.

8

Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.

Fossella FV, Lippman SM, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E, Hardy J, O'Brien M, Haynes TR, Wolen RL. Fossella FV, et al. Among authors: lippman sm. Invest New Drugs. 1991 Nov;9(4):357-9. doi: 10.1007/BF00183581. Invest New Drugs. 1991. PMID: 1804813 Clinical Trial. No abstract available.

9

Biomarkers as intermediate end points in chemoprevention trials.

Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Lippman SM, et al. J Natl Cancer Inst. 1990 Apr 4;82(7):555-60. doi: 10.1093/jnci/82.7.555. J Natl Cancer Inst. 1990. PMID: 2179569 Review. No abstract available.

10

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Hong WK, et al. Among authors: lippman sm. N Engl J Med. 1990 Sep 20;323(12):795-801. doi: 10.1056/NEJM199009203231205. N Engl J Med. 1990. PMID: 2202902 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters